financetom
Business
financetom
/
Business
/
AbbVie Buys Celsius Therapeutics for $250 million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AbbVie Buys Celsius Therapeutics for $250 million
Jun 27, 2024 7:07 AM

09:33 AM EDT, 06/27/2024 (MT Newswires) -- AbbVie ( ABBV ) said Thursday it has acquired privately held biotechnology company Celsius Therapeutics for $250 million in cash, subject to certain customary adjustments.

Price: 170.76, Change: -0.39, Percent Change: -0.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Victory Capital Withdraws Proposal to Buy Janus Henderson
Victory Capital Withdraws Proposal to Buy Janus Henderson
Mar 24, 2026
04:43 PM EDT, 03/24/2026 (MT Newswires) -- Victory Capital ( VCTR ) said Tuesday it has withdrawn its proposal to acquire Janus Henderson Group ( JHG ) . Victory said it was only prepared to move forward with a negotiated, consensual transaction that had the full support of the Janus Henderson Special Committee. Earlier today, Janus Henderson ( JHG )...
Vail and Alterra ski resorts face consumer class action over lift ticket prices
Vail and Alterra ski resorts face consumer class action over lift ticket prices
Mar 24, 2026
March 24 (Reuters) - Four skiers have filed a proposed class action against Vail Resorts ( MTN ) and Alterra Mountain Co in U.S. federal court, accusing the companies of exploiting their grip on the industry to artificially inflate the cost of skiing and snowboarding across the country. The lawsuit, filed on Monday in U.S. federal court in Denver, said...
OpenAI to discontinue Sora video platform
OpenAI to discontinue Sora video platform
Mar 24, 2026
March 24 (Reuters) - OpenAI is discontinuing its video generation tool Sora in a surprise move announced on Tuesday, as the ChatGPT maker ramps up focus on enterprise offerings amid plans for a potential market debut later this year. We're saying goodbye to Sora... we know this news is disappointing. We'll share more soon, including timelines for the app and...
Celestica Announces Board Chair Succession and Appointment of New Director
Celestica Announces Board Chair Succession and Appointment of New Director
Mar 24, 2026
04:42 PM EDT, 03/24/2026 (MT Newswires) -- Celestica ( CLS ) was last seen up 1.3% in after-hours New York trading d after the company on Tuesday said board chair Michael Wilson will retire prior to its May 19 annual meeting and will not stand for re-election. CEO Rob Mionis will assume the role of board chair at that time,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved